Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma

• Michelle A. McNally, BSN,
• Ramya Vangipuram, MD,
• Matthew T. Campbell, MD,
• Priyadharsini Nagarajan, MD, PhD,
• Anisha B. Patel, MD,
• Jonathan L. Curry, MD,
• Meghan Heberton, MD

Affiliations

Michelle A. McNally, BSN

John P. and Katherine G. McGovern Medical School, Houston, Texas

Ramya Vangipuram, MD

Department of Dermatology, John P. and Kathrine G. McGovern Medical School, Houston, Texas

Matthew T. Campbell, MD

Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, Texas

Priyadharsini Nagarajan, MD, PhD

Department of Pathology, MD Anderson Cancer Center, Houston, Texas

Anisha B. Patel, MD

Department of Dermatology, John P. and Kathrine G. McGovern Medical School, Houston, Texas; Department of Dermatology, MD Anderson Cancer Center, Houston, Texas

Jonathan L. Curry, MD

Department of Pathology, MD Anderson Cancer Center, Houston, Texas

Meghan Heberton, MD

Department of Dermatology, MD Anderson Cancer Center, Houston, Texas; Correspondence to: Dr. Meghan Heberton, MD, 1515 Holcombe Blvd/Unit 1452, Houston, TX, 77030-4009.